Skip to main content
Hot Flashes Without Hormone Therapy: What Can You Discuss?
Patient Education
Hormone Health5 min read

Hot Flashes Without Hormone Therapy: What Can You Discuss?

Explore nonhormonal approaches to hot flashes, questions about prescription options, and why treatment choice and monitoring should be individualized.

Hot flashes that interrupt a meeting or repeatedly wake you at night deserve a treatment conversation. If you cannot use hormone therapy, prefer not to use it, or are still weighing your options, the discussion does not have to end there. Evidence-supported nonhormonal approaches are available.[1] The useful starting point is your goal. Is the biggest problem daytime episodes, disrupted sleep, or having to plan activities around symptoms? Describing that impact gives your clinician more information than simply calling the flashes "bad."

🎯

Start with the symptom you want to change

For your appointment, write down a few representative episodes: when they happened, whether they interrupted sleep, and what you had to stop doing. Include current medicines, supplements, previous treatments, and why you stopped them. This is a discussion aid, not a test that determines which treatment you need. You might say, "I can manage the daytime warmth, but I wake up several times and cannot concentrate the next morning." That makes it easier to agree on what a worthwhile improvement would look like and when to reassess it.

πŸ“‹

Nonhormonal does not mean one type of treatment

The Menopause Society describes prescription options including certain antidepressants and gabapentin, as well as medicines developed specifically for hot flashes. Some options are approved for this use; others are prescribed off-label. An antidepressant may be considered for hot flashes even when a person does not have depression.[1] Ask which symptom the proposed medicine targets, whether this use is FDA-approved, and how your other prescriptions affect the choice. These are examples of treatment categories, not a complete list or a recommendation to start a particular drug. Behavioral approaches also deserve a precise explanation. The Society's 2023 position statement supports cognitive behavioral therapy and clinical hypnosis for vasomotor symptoms. It does not recommend supplements or herbal remedies as established hot-flash treatments. Comfort measures and a product's "natural" label should not be confused with evidence that it treats the condition.[2]

⚠️

Monitoring is part of the treatment decision

A nonhormonal medicine can still have important risks. For example, FDA warns that fezolinetant can rarely cause serious liver injury and requires liver testing before and during treatment. Patients taking it should stop it and seek medical attention immediately for symptoms suggesting liver injury, such as yellowing skin or eyes, dark urine, or new unusual fatigue.[3] This example is a reason to discuss monitoring, not a reason to assume all nonhormonal treatments have the same risks. Ask what applies to the exact medicine being considered, including interactions, follow-up, and what to do if side effects occur.

πŸ’¬

Leave with a plan you can explain

Before the visit ends, try summarizing the decision: "We are treating this symptom with this approach, and we will review the response at this time." Ask whom to contact if the treatment is unaffordable or difficult to use, rather than quietly abandoning it. For prescription questions, contact Sierra Compounding Pharmacy in Rancho Cucamonga. Your clinician determines whether hormonal or nonhormonal treatment fits your medical history; compounding is not a required step in either discussion. This article provides general education and does not replace individualized medical advice.

πŸ“š

References

  • 1. The Menopause Society. Hot Flashes. https://menopause.org/patient-education/menopause-topics/hot-flashes
  • 2. The North American Menopause Society. The 2023 nonhormone therapy position statement. Menopause. 2023;30(6):573-590. https://pubmed.ncbi.nlm.nih.gov/37252752/
  • 3. U.S. Food and Drug Administration. Warning about serious liver injury with Veozah (fezolinetant). https://www.fda.gov/drugs/drug-safety-communications/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due
  • Sources accessed October 29, 2026. Access date is not a source publication date.
πŸ’Š
Pharmacist Note

Sierra Compounding Pharmacy Can Help

All compounded medications require a valid prescription from a licensed healthcare provider. If your provider has determined that a customized compounded formulation is appropriate for your needs, Sierra Compounding Pharmacy β€” located in Rancho Cucamonga β€” is here to help. We serve patients throughout the Inland Empire, including San Bernardino County, Riverside County, and surrounding communities.

Ready to Get Started?

Questions About Compounded Medications?

Sierra Compounding Pharmacy serves patients and providers throughout the Inland Empire. Contact us or ask your provider to send a prescription directly.